drugset / Trial / NCT01171118

Phamacological Reversal of Airway Instability During Sedation

NCT01171118

Completed 10 enrolled University of Rochester
RandomizedCrossoverTriple-blindTreatment

Summary

The investigators are attempting to demonstrate a decrease in the frequency and severity of sedation-induced respiratory arrhythmias(central and obstructive apneas) with pharmacological pre-treatment in this pilot project and then eventually to understand the mechanisms behind this decrease. The efficacy and mechanisms of these treatments, while evaluated during sleep in Obstructed Sleep Apnea (OSA) patients, have not been systematically studied during sedation in either normal subjects or OSA patients. The agent to be assessed in this study in physostigmine versus placebo.

Timeline

Start
2009-08
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxygen Other / unclassified
Subject Physostigmine Small molecule

Indications

No indication recorded.